{
    "nctId": "NCT04740697",
    "briefTitle": "Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer",
    "officialTitle": "Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Rate of patients who adhere to tamoxifen treatment.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u2265 18 years at entry into the study.\n2. Patient treated for hormone-dependent localized breast cancer requiring adjuvant Hormonal Therapy (HT) with tamoxifen.\n3. Patients treated with tamoxifen for a maximum of 1 to 3 years.\n4. Patient affiliated with a Social Security system in France.\n5. Patients who signed informed consent prior to inclusion in the study and prior to any specific study procedures.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women.\n2. Any psychological, family, geographical or sociological condition that does not allow the medical follow-up and/or the procedures foreseen in the study protocol to be respected.\n3. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).",
    "sex": "FEMALE",
    "minimumAge": "18 Months",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}